Literature DB >> 20139988

Raising the NKT cell family.

Dale I Godfrey1, Sanda Stankovic, Alan G Baxter.   

Abstract

Natural killer T cells (NKT cells) are CD1d-restricted, lipid antigen-reactive, immunoregulatory T lymphocytes that can promote cell-mediated immunity to tumors and infectious organisms, including bacteria and viruses, yet paradoxically they can also suppress the cell-mediated immunity associated with autoimmune disease and allograft rejection. Furthermore, in some diseases, such as atherosclerosis and allergy, NKT cell activity can be deleterious to the host. Although the precise means by which these cells carry out such contrasting functions is unclear, recent studies have highlighted the existence of many functionally distinct NKT cell subsets. Because their frequency and number vary widely between individuals, it is important to understand the mechanisms that regulate the development and maintenance of NKT cells and subsets thereof, which is the subject of this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139988     DOI: 10.1038/ni.1841

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  129 in total

1.  Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.

Authors:  L D Poulton; M J Smyth; C G Hawke; P Silveira; D Shepherd; O V Naidenko; D I Godfrey; A G Baxter
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

2.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

Review 3.  CD1d- and MR1-restricted invariant T cells: of mice and men.

Authors:  Emmanuel Treiner; Olivier Lantz
Journal:  Curr Opin Immunol       Date:  2006-07-25       Impact factor: 7.486

Review 4.  CD1 antigen presentation: how it works.

Authors:  Duarte C Barral; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

5.  Long-term retention of mature NK1.1+ NKT cells in the thymus.

Authors:  Stuart P Berzins; Finlay W McNab; Claerwen M Jones; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

6.  CD1d-restricted NKT cells: an interstrain comparison.

Authors:  K J Hammond; D G Pellicci; L D Poulton; O V Naidenko; A A Scalzo; A G Baxter; D I Godfrey
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.

Authors:  Nadia Duarte; Martin Stenström; Susana Campino; Marie-Louise Bergman; Marie Lundholm; Dan Holmberg; Susanna L Cardell
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  The vitamin D receptor is required for iNKT cell development.

Authors:  Sanhong Yu; Margherita T Cantorna
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

9.  iNKT cell development is orchestrated by different branches of TGF-beta signaling.

Authors:  Jean-Marc Doisne; Laurent Bartholin; Kai-Ping Yan; Céline N Garcia; Nadia Duarte; Jean-Benoît Le Luduec; David Vincent; Farhan Cyprian; Branka Horvat; Sylvie Martel; Ruth Rimokh; Régine Losson; Kamel Benlagha; Julien C Marie
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

10.  Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.

Authors:  Dale Christiansen; Julie Milland; Effie Mouhtouris; Hilary Vaughan; Daniel G Pellicci; Malcolm J McConville; Dale I Godfrey; Mauro S Sandrin
Journal:  PLoS Biol       Date:  2008-07-15       Impact factor: 8.029

View more
  301 in total

1.  Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Authors:  Y-G Chen; S-W Tsaih; D V Serreze
Journal:  Genes Immun       Date:  2011-09-22       Impact factor: 2.676

2.  A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice.

Authors:  Qian Qi; Weishan Huang; Yuting Bai; Gabriel Balmus; Robert S Weiss; Avery August
Journal:  J Immunol       Date:  2012-03-07       Impact factor: 5.422

Review 3.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

4.  Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.

Authors:  Sunil K Joshi; Gillian A Lang; T Scott Devera; Amy M Johnson; Susan Kovats; Mark L Lang
Journal:  J Leukoc Biol       Date:  2012-02-13       Impact factor: 4.962

Review 5.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

6.  The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation.

Authors:  Yajun Wang; Chawon Yun; Beixue Gao; Yuanming Xu; Yana Zhang; Yiming Wang; Qingfei Kong; Fang Zhao; Chyung-Ru Wang; Sharon Y R Dent; Jian Wang; Xiangping Xu; Hua-Bin Li; Deyu Fang
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

7.  Changes in NK and NKT cells in mesenteric lymph nodes after a Schistosoma japonicum infection.

Authors:  Xueping Luo; Hongyan Xie; Dianhui Chen; Xiuxue Yu; Fan Wu; Lu Li; Changyou Wu; Jun Huang
Journal:  Parasitol Res       Date:  2013-12-10       Impact factor: 2.289

8.  Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.

Authors:  Xiangshu Wen; Ping Rao; Leandro J Carreño; Seil Kim; Agnieszka Lawrenczyk; Steven A Porcelli; Peter Cresswell; Weiming Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 9.  Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.

Authors:  Bruce R Blazar; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

Review 10.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.